Biotechnologist Feng Zhang of the Broad Institute (a joint venture of MIT and Harvard University) was awarded a patent for CRISPR gene-editing technology in 2014. But two other scientists — Jennifer Doudna, of the University of California, Berkeley, and Emmanuelle Charpentier, then of the University of Vienna — published their description of the underlying biology first. Susan Walsh/AP hide caption

toggle caption
Susan Walsh/AP

Broad Institute Wins Big Battle Over CRISPR Gene-Editing Patent

  • Download
  • <iframe src="https://www.npr.org/player/embed/515459773/515529417" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Emmanuelle Charpentier (left) and Jennifer Doudna have a case for being the inventors of CRISPR-cas9, a transformative tool for gene editing. Miguel Riopa/AFP/Getty Images hide caption

toggle caption
Miguel Riopa/AFP/Getty Images

Scientists Battle In Court Over Lucrative Patents For Gene-Editing Tool

  • Download
  • <iframe src="https://www.npr.org/player/embed/504454201/504467257" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Medical geneticist Dr. Harry Ostrer (center) talks to the press outside the U.S. Supreme Court on Monday. The court heard oral arguments on the highly charged question of whether human genes can be patented. Mladen Antonov/AFP/Getty Images hide caption

toggle caption
Mladen Antonov/AFP/Getty Images

Justices Appear Skeptical Of Patenting Human Genes

  • Download
  • <iframe src="https://www.npr.org/player/embed/177369914/177369895" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript